1. Clinical Overview
A fixed-dose combination of a typical antipsychotic (trifluoperazine) and an anticholinergic/antispasmodic agent (isopropamide). Primarily used for the management of psychosomatic and functional gastrointestinal disorders where anxiety and hypermotility are prominent features. Isopropamide acts as an antispasmodic to reduce gastrointestinal smooth muscle contractions and secretions, while trifluoperazine provides anxiolytic and antipsychotic effects to address the underlying or associated psychological component.
| Onset | Duration | Bioavailability |
|---|---|---|
| Trifluoperazine: 1-2 hours (oral). Isopropamide: 1-2 hours (oral). | Trifluoperazine: Up to 12-24 hours. Isopropamide: 10-12 hours. | Trifluoperazine: Variable, approximately 40-60% (oral). Isopropamide: Not well quantified but considered moderate. |
2. Mechanism of Action
The combination exerts a dual action. Trifluoperazine acts centrally as a dopamine D2 receptor antagonist in the mesolimbic pathway, reducing psychotic symptoms and anxiety. It also has alpha-1 adrenergic blocking and anticholinergic properties. Isopropamide acts peripherally as a competitive antagonist at muscarinic acetylcholine receptors (M1, M3) in the gastrointestinal tract, inhibiting smooth muscle contraction and glandular secretions (e.g., gastric acid). This reduces cramping, hypermotility, and spasms.
3. Indications & Uses
- Management of psychosomatic disorders with gastrointestinal manifestations (e.g., irritable bowel syndrome with anxiety)
- Functional gastrointestinal disorders with anxiety and hypermotility
- Peptic ulcer disease as adjunctive therapy for anxiety-related exacerbations (historical use, now less common)
4. Dosage & Administration
Adult Dosage: One tablet (Isopropamide 5mg + Trifluoperazine 1mg) twice daily. May be adjusted based on response and tolerability. Maximum usually 3 tablets per day. Initiate at lower dose in sensitive patients.
Administration: Oral administration. Can be taken with or without food. Taking with food may reduce gastric irritation. Swallow whole with a glass of water. Do not crush or chew. Avoid alcohol completely.
5. Side Effects
Common side effects may include:
- Dry mouth (xerostomia)
- Blurred vision (mydriasis and cycloplegia)
- Constipation
- Drowsiness/sedation
- Dizziness
- Postural hypotension
- Nasal congestion
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Potentiated sedation, respiratory depression, impaired motor skills | Major |
| Anticholinergics (Trihexyphenidyl, Atropine, TCAs) | Additive anticholinergic toxicity: severe dry mouth, urinary retention, ileus, hyperthermia, confusion | Major |
| Levodopa, Dopamine Agonists | Mutual antagonism; reduced efficacy of both | Major |
| Antihypertensives (especially Alpha-blockers, Nitrates) | Enhanced hypotensive effect, risk of severe orthostasis | Moderate |
| QTc-prolonging drugs (Class IA/III antiarrhythmics, Macrolides, Fluoroquinolones) | Increased risk of Torsades de Pointes | Major |
| Enzyme Inducers (Phenobarbital, Carbamazepine, Rifampicin) | Reduced plasma levels of trifluoperazine, decreased efficacy | Moderate |
| Enzyme Inhibitors (Fluoxetine, Paroxetine - CYP2D6 inhibitors) | Increased plasma levels of trifluoperazine, risk of toxicity | Moderate |
| Metoclopramide, Prochlorperazine | Increased risk of extrapyramidal symptoms | Moderate |
7. Patient Counselling
- DO take exactly as prescribed. DO NOT double the dose if missed.
- DO inform all your doctors and dentists you are taking this medicine.
- DO rise slowly from sitting/lying position to avoid dizziness.
- DO maintain good oral hygiene to manage dry mouth (sugar-free gum/candies).
- DO use sunglasses and sunscreen due to photosensitivity risk.
- DO NOT stop taking suddenly without doctor's advice; taper may be needed.
- DO NOT consume alcohol in any form.
- DO NOT take over-the-counter cold, allergy, or sleep aids without consulting doctor (may contain anticholinergics or sedatives).
8. Toxicology & Storage
Overdose: Primarily an extension of pharmacological effects: Severe CNS depression (coma), profound hypotension, tachycardia, hyperthermia or hypothermia, severe anticholinergic crisis (flushed, hot, dry skin; dilated pupils; ileus; urinary retention; delirium), extrapyramidal symptoms, cardiac arrhythmias (QTc prolongation), seizures, respiratory depression.
Storage: Store below 30°C, in a cool, dry place. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach and sight of children.